| Fund ID | 805-4817907553 |
| Fund type | Other Private Fund — FUND OF FUNDS |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | Yes |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Chcp Global Securities, L.P. | Other Private | $976M |
| Altair Chp Fund, LLC | Hedge | $931.8M |
| Chcp Value Fund, L.P. | Other Private | $272M |
Bca Select Series 4 - Life Sciences Investments (lsi) reports $3.9 million in gross assets, among the top 87% of private funds by size.
The stated minimum investment is $250,000.
Bca Select Series 4 - Life Sciences Investments (lsi) is managed by Cresset Asset Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.